Emmanuel Chigutsa Selected Research

Blood Glucose (Blood Sugar)

1/2023

Once-Weekly Basal Insulin Fc Demonstrated Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With Type 2 Diabetes: A Phase 2 Randomized Control Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emmanuel Chigutsa Research Topics

Disease

6	Tuberculosis (Tuberculoses) 11/2018 - 09/2011
4	COVID-19 01/2022 - 11/2021
3	Hypoglycemia (Reactive Hypoglycemia) 05/2023 - 01/2023
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2023
1	Amyloid Plaque 04/2023
1	Disease Progression 04/2023
1	Alzheimer Disease (Alzheimer's Disease) 04/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023
1	Infections 11/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2018
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2018
1	Acute Coronary Syndrome 01/2018
1	Neoplasms (Cancer) 01/2017
1	Pulmonary Tuberculosis 01/2015
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 07/2012
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2008

Drug/Important Bio-Agent (IBA)

3	Insulin (Novolin)FDA Link 01/2023 - 01/2023
3	Monoclonal AntibodiesIBA 01/2022 - 11/2018
3	Rifampin (Rifampicin)FDA LinkGeneric 01/2015 - 09/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2023
2	insulin degludecIBA 01/2023 - 01/2023
2	bamlanivimabIBA 01/2022 - 12/2021
2	bamlanivimab and etesevimab drug combinationIBA 01/2022 - 11/2021
2	Moxifloxacin (Avelox)FDA Link 11/2018 - 01/2014
2	Pyrazinamide FDA LinkGeneric 01/2015 - 09/2011
2	Ethambutol (Myambutol)FDA LinkGeneric 01/2015 - 09/2011
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2015 - 09/2011
1	Glucagon (Glukagon)FDA Link 05/2023
1	donanemabIBA 04/2023
1	Amyloid (Amyloid Fibrils)IBA 04/2023
1	Blood Glucose (Blood Sugar)IBA 01/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023
1	VaccinesIBA 01/2022
1	Neutralizing AntibodiesIBA 11/2021
1	abemaciclibIBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 11/2018
1	ixekizumabIBA 11/2018
1	Adenosine Diphosphate (ADP)IBA 01/2018
1	Purinergic P2Y Receptor AntagonistsIBA 01/2018
1	Prasugrel Hydrochloride FDA Link 01/2018
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	LigandsIBA 01/2017
1	necitumumabIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 02/2013
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 07/2012
1	FluoroquinolonesIBA 07/2012
1	efavirenz (Sustiva)FDA Link 04/2008
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 04/2008

Therapy/Procedure

6	Therapeutics 04/2023 - 01/2015
2	Glycemic Control 01/2023 - 01/2023
2	Drug Therapy (Chemotherapy) 11/2018 - 01/2017
1	Injections 01/2023
1	Duration of Therapy 11/2018